Artesunate

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D. BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Artesunate is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • FDA approved only artemether-lumefantrine combination (see this module for details).
    • Artesunate (as single agent) is available for emergency use in the U.S. (contact CDC) for severe falciparum malaria.

NON-FDA APPROVED USES

  • Mild to moderate malaria falciparum.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: October 2, 2018